Investors love biotech stocks for the lottery ticket-like returns they can offer if a company strikes medical gold. Case in point: Arrowhead (NASDAQ:ARWR), …
Shares of drug maker Arrowhead Research (NASDAQ:ARWR) rose nearly 9% today on heavy volume, thanks to new clinical data from an ongoing phase I study …
Arrowhead Research (NASDAQ:ARWR) is a mover and shaker out on the Street today, with investors sparking the stock on an almost 16% upturn. …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced financial results for its fiscal 2017 first quarter ended December 31, 2016. Selected Fiscal 2017 First Quarter and …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) announced financial results for its fiscal 2016 fourth quarter and year ended September 30, 2016. The company is hosting …
Valeant Pharmaceuticals Intl Inc Valeant Pharmaceuticals Intl Inc (NYSE:VRX) saw its shares falling nearly 10% today, after Dow Jones reported that talks to sell …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) are currently plummeting 62% in pre-market trading after yesterday’s announcement that the biotech firm has discontinued all of its …
Shares of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) tumbled nearly 60% in after-hours trading, after the RNAi therapeutics company said that it will discontinue development of clinical stage …
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) delivered a poster presentation with Phase 1 clinical data and an oral presentation with preclinical data on ARC-AAT, its …
Chardan is divided when it comes to forecasts moving forward for biotech stocks Novavax, Inc. (NASDAQ:NVAX) and Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR).
